Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Letter from RG out

Re: cytoman, "I'll take another 100 licensees @ $200k each."

I'd need to move some decimal points before I'd agree.

That $200K times 100 licenses would gross (before expenses and tax) $20 million - assuming that's after the 50/50 split with TPL.

With around 400 million shares outstanding that might net us all of 5 cents a share. There are (were) only around 400 prospects for licensing. Bad deal @ $200K.

We need to be talking big (really big) income to get the kind of SP we're looking for.



Share
New Message
Please login to post a reply